Month: June 2024

#StayInformed: June 2024 PubMed curation

Migayron et al. Front Immunol➜ DOI: 10.3389/fimmu.2024.1405215Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?This is an interesting review which approaches indirectly some of the paradoxical findings observed using targeted therapies in AD. Silverberg et al JAAD➜ DOI: 10.1016/j.jaad.2024.05.023Tapinarof Cream 1% Once Daily: Significant Efficacy in the Treatment of Moderate to Severe Atopic Dermatitis [...] Read More

June 2024 digest

What PubMed tell us about current trends in AD research? Dear Colleagues, Dear Friends, Since the approval of dupilumab for severe adult AD by the FDA in 2017, published AD research has been tremendously driven by RCTs and associated research concerning dupilumab and other new systemic/ topical therapies designed to control TH2 inflammation. The influence […]

Read More

ISAD Society with WHO Initiative on AI for skin conditions

We are proud to be a participating institution with World Health Organization on Global Initiative on AI for Skin Conditions! This WHO Neglected Tropical Diseases (NTD)-led Global Initiative discusses progress, challenges, gaps and solutions in developing and implementing artificial augmented intelligence-based apps as a capacity building and monitoring tool for skin NTDs and selected common skin conditions […]

Read More